PARAMOUNT BIOCAPITAL ASSET MANAGEMENT

paramount-biocapital-asset-management-logo

Paramount BioSciences is a global pharmaceutical development and healthcare investment firm that conceives, nurtures, and supports new biotechnology and life-sciences companies. The company has a keen eye for finding and developing novel therapeutic medicines that have, in our opinion, significant market potential. It assesses promising drug candidates from around the globe, from academic centers to biotechnology firms to pharmaceutical companies. Once compounds are in-licensed, selected memb... ers of the Paramount BioSciences Executive Team -- each member has significant life sciences industry experience, as described in their bios -- supported by approximately 80 in-house professionals, manages their entire development cycle, supporting all aspects of drug development including manufacturing, formulation, technology transfer, pharmacology, toxicology, clinical development, regulatory, quality assurance, commercialization, and life cycle management. After technologies are in-licensed and management teams are recruited to run portfolio companies built around novel therapeutics, Paramount BioSciences arranges for financing through its affiliate Paramount BioCapital, Inc., a FINRA registered broker-dealer. The affiliateรขโ‚ฌโ„ขs financial professionals have experience with securities and corporate transactions, including financings and mergers and acquisitions.

#SimilarOrganizations #People #Financial #More

PARAMOUNT BIOCAPITAL ASSET MANAGEMENT

Founded:
2008-06-05

Status:
Active


Similar Organizations

avid-radiopharmaceuticals-logo

Avid Radiopharmaceuticals

Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.

mast-therapeutics-logo

Mast Therapeutics

Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.

polycore-therapeutics-logo

PolyCore Therapeutics

PolyCore Therapeuticsโ€™ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.

Current Employees Featured

not_available_image

Lindsay Rosenwald
Lindsay Rosenwald Co-founder @ Paramount BioCapital Asset Management
Co-founder

not_available_image

Jay Lobell
Jay Lobell President & COO @ Paramount BioCapital Asset Management
President & COO

Founder


not_available_image

Lindsay Rosenwald

Investments List

Date Company Article Money raised
2009-08-20 CEL-SCI Paramount BioCapital Asset Management investment in Post-IPO Equity - CEL-SCI 4.4 M USD
2007-04-25 Innovive Pharmaceuticals Paramount BioCapital Asset Management investment in Venture Round - Innovive Pharmaceuticals 15 M USD
2006-06-27 Genelabs Technologies Paramount BioCapital Asset Management investment in Venture Round - Genelabs Technologies 8.3 M USD
2006-05-03 Ziopharm oncology Paramount BioCapital Asset Management investment in Post-IPO Equity - Ziopharm oncology 37 M USD
2005-01-12 Chelsea Therapeutics International Paramount BioCapital Asset Management investment in Post-IPO Equity - Chelsea Therapeutics International 14.5 M USD

More informations about "Paramount BioCapital Asset Management" on Search Engine